scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1009016129 |
P356 | DOI | 10.1186/S13073-016-0299-7 |
P2888 | exact match | https://scigraph.springernature.com/pub.10.1186/s13073-016-0299-7 |
P932 | PMC publication ID | 4840970 |
P698 | PubMed publication ID | 27102666 |
P50 | author | John M. Davis | Q57081275 |
Veena Taneja | Q57316689 | ||
P2093 | author name string | Jun Chen | |
Eric L Matteson | |||
Patricio Jeraldo | |||
Heidi Nelson | |||
Eric V Marietta | |||
Joseph Murray | |||
Kerry Wright | |||
P2860 | cites work | Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis | Q21128781 |
Identifying Important Risk Factors for Survival in Kidney Graft Failure Patients Using Random Survival Forests | Q22673963 | ||
Enterotypes of the human gut microbiome | Q24489818 | ||
Obesity and the gut microbiota | Q37944979 | ||
The multifactorial role of neutrophils in rheumatoid arthritis | Q38219055 | ||
New humanized HLA-DR4-transgenic mice that mimic the sex bias of rheumatoid arthritis. | Q40256546 | ||
Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors | Q40532147 | ||
Polarized secretion of CXC chemokines by human intestinal epithelial cells in response to Bacteroides fragilis enterotoxin: NF-kappa B plays a major role in the regulation of IL-8 expression | Q40813378 | ||
The gut anaerobe Faecalibacterium prausnitzii uses an extracellular electron shuttle to grow at oxic-anoxic interphases. | Q42037672 | ||
Rheumatoid arthritis, Proteus, anti-CCP antibodies and Karl Popper | Q43246805 | ||
Aging, diabetes, and renal failure catalyze the oxidation of lysyl residues to 2-aminoadipic acid in human skin collagen: evidence for metal-catalyzed oxidation mediated by alpha-dicarbonyls | Q46617579 | ||
The gut microbiome in health and disease | Q46913518 | ||
Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis. | Q51329765 | ||
Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis--a pilot study | Q79306438 | ||
Fecal microbiota in early rheumatoid arthritis | Q81403677 | ||
NF-kappa B activation pathway is essential for the chemokine expression in intestinal epithelial cells stimulated with Clostridium difficile toxin A | Q83960118 | ||
Obesity and comorbidity are independently associated with a failure to achieve remission in patients with established rheumatoid arthritis | Q87533360 | ||
2-Aminoadipic acid is a biomarker for diabetes risk | Q24617890 | ||
A core gut microbiome in obese and lean twins | Q24649648 | ||
Leflunomide: mode of action in the treatment of rheumatoid arthritis | Q24675005 | ||
T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma | Q28506783 | ||
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment | Q28710518 | ||
The human microbiome project | Q29547661 | ||
Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells | Q29614271 | ||
Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences | Q29615050 | ||
Dynamics and associations of microbial community types across the human body | Q31158807 | ||
Arthritis susceptibility and the gut microbiome | Q33358523 | ||
Mechanism by which HLA-DR4 regulates sex-bias of arthritis in humanized mice | Q33886419 | ||
Innate immune recognition of the microbiota promotes host-microbial symbiosis | Q33945889 | ||
Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease | Q34241773 | ||
Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis | Q34250412 | ||
Loss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible 0401 mice but not arthritis-resistant 0402 mice | Q34254430 | ||
Auricular chondritis in NOD.DQ8.Abetao (Ag7-/-) transgenic mice resembles human relapsing polychondritis | Q34265750 | ||
Associating microbiome composition with environmental covariates using generalized UniFrac distances | Q34282663 | ||
Twin concordance rates for rheumatoid arthritis: results from a nationwide study. | Q34357436 | ||
Uncooked, lactobacilli-rich, vegan food and rheumatoid arthritis | Q34466081 | ||
Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion | Q34473984 | ||
Anti-CXCL5 therapy ameliorates IL-17-induced arthritis by decreasing joint vascularization | Q34802798 | ||
Microbiome and probiotics: link to arthritis | Q35170981 | ||
IM-TORNADO: a tool for comparison of 16S reads from paired-end libraries | Q35519676 | ||
Metagenomic biomarker discovery and explanation | Q35557728 | ||
Body mass index and the risk of rheumatoid arthritis: a systematic review and dose-response meta-analysis | Q35577320 | ||
The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment | Q35716503 | ||
Mechanisms of disease: Genetic susceptibility and environmental triggers in the development of rheumatoid arthritis | Q36577538 | ||
Contribution of obesity to the rise in incidence of rheumatoid arthritis | Q36999878 | ||
Bugs & us: the role of the gut in autoimmunity | Q37592375 | ||
CXCL5-secreting pulmonary epithelial cells drive destructive neutrophilic inflammation in tuberculosis | Q37602224 | ||
Influence of microbial environment on autoimmunity. | Q37657060 | ||
Role of HLA class II genes in susceptibility/resistance to inflammatory arthritis: studies with humanized mice. | Q37700779 | ||
Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease | Q37735334 | ||
Infection and rheumatoid arthritis: still an open question. | Q37870647 | ||
Environmental exposures and rheumatoid arthritis risk | Q37904821 | ||
P433 | issue | 1 | |
P921 | main subject | rheumatoid arthritis | Q187255 |
P304 | page(s) | 43 | |
P577 | publication date | 2016-04-21 | |
P1433 | published in | Genome Medicine | Q15816848 |
P1476 | title | An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis | |
P478 | volume | 8 |
Q60947155 | A Phylogeny-Regularized Sparse Regression Model for Predictive Modeling of Microbial Community Data |
Q48196042 | A bidirectional association between the gut microbiota and CNS disease in a biphasic murine model of multiple sclerosis |
Q60045071 | A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist? |
Q33827644 | Aberrant intestinal microbiota due to IL-1 receptor antagonist deficiency promotes IL-17- and TLR4-dependent arthritis |
Q41191451 | Aggravation of collagen-induced arthritis by orally administered Porphyromonas gingivalis through modulation of the gut microbiota and gut immune system |
Q28821054 | Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease Status |
Q47108321 | Alteration of the intestinal microbiome characterizes preclinical inflammatory arthritis in mice and its modulation attenuates established arthritis. |
Q37487983 | Alterations of the gut microbiome in Chinese patients with systemic lupus erythematosus |
Q89846751 | Altered Gut Microbiome Profile in Patients With Pulmonary Arterial Hypertension |
Q39026607 | Altered gut microbiota in RA: implications for treatment |
Q57471139 | An Increased Abundance of Clostridiaceae Characterizes Arthritis in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Cross-sectional Study |
Q92314304 | An Overview of the Intrinsic Role of Citrullination in Autoimmune Disorders |
Q59138374 | Analysis of Gut Microbiota in Rheumatoid Arthritis Patients: Disease-Related Dysbiosis and Modifications Induced by Etanercept |
Q38872112 | Arthritis models: usefulness and interpretation |
Q104510320 | Associations between gut microbiota and genetic risk for rheumatoid arthritis in the absence of disease: a cross-sectional study |
Q92878332 | Characteristic gut microbiota and predicted metabolic functions in women with PCOS |
Q28468330 | Chemical Isotope Labeling LC-MS for Monitoring Disease Progression and Treatment in Animal Models: Plasma Metabolomics Study of Osteoarthritis Rat Model |
Q91917519 | Comparative analysis of the vaginal microbiome of pregnant women with either Trichomonas vaginalis or Chlamydia trachomatis |
Q55399086 | Deciphering microbial interactions in synthetic human gut microbiome communities. |
Q90460979 | Detection of Increased Relative Expression Units of Bacteroides and Prevotella, and Decreased Clostridium leptum in Stool Samples from Brazilian Rheumatoid Arthritis Patients: A Pilot Study |
Q60954896 | Diet, Microbiota, and Gut Permeability-The Unknown Triad in Rheumatoid Arthritis |
Q94467571 | Disordered Gut Microbiota in Children Who Have Chronic Pancreatitis and Different Functional Gene Mutations |
Q38624037 | Dissection of the module network implementation "LemonTree": enhancements towards applications in metagenomics and translation in autoimmune maladies. |
Q38690943 | Distinct roles for dietary lipids and Porphyromonas gingivalis infection on atherosclerosis progression and the gut microbiota |
Q91788135 | Drug-microbiota interactions and treatment response: Relevance to rheumatoid arthritis |
Q64967198 | Dynamic Alterations in the Gut Microbiota of Collagen-Induced Arthritis Rats Following the Prolonged Administration of Total Glucosides of Paeony. |
Q47154062 | EBI Metagenomics in 2017: enriching the analysis of microbial communities, from sequence reads to assemblies. |
Q91963280 | Effect of Short-Term Dietary Intervention and Probiotic Mix Supplementation on the Gut Microbiota of Elderly Obese Women |
Q55005409 | Effects of preservation method on canine (Canis lupus familiaris) fecal microbiota. |
Q42657792 | Enrichment allows identification of diverse, rare elements in metagenomic resistome-virulome sequencing |
Q64067989 | Fecal Metabolomics and Potential Biomarkers for Systemic Lupus Erythematosus |
Q55360165 | Fecal Microbiota Composition Drives Immune Activation in HIV-infected Individuals. |
Q90309981 | Fecal microbiota characteristics of Chinese patients with primary IgA nephropathy: a cross-sectional study |
Q57677235 | Fecal microbiota profile in a group of myasthenia gravis patients |
Q56536590 | Generalized Hotelling's test for paired compositional data with application to human microbiome studies |
Q64361004 | Genomic and phenotypic description of the newly isolated human species Collinsella bouchesdurhonensis sp. nov |
Q64993009 | Gut Microbial Composition and Function Are Altered in Patients with Early Rheumatoid Arthritis. |
Q90301486 | Gut Microbiome in Inflammatory Bowel Disease and Other Chronic Immune-Mediated Inflammatory Diseases |
Q60948654 | Gut Microbiota and Endothelial Dysfunction Markers in Obese Mexican Children and Adolescents |
Q41997075 | Gut Microbiota and IL-17A: Physiological and Pathological Responses |
Q33874066 | Gut bacterial peptides with autoimmunity potential as environmental trigger for late onset complex diseases: In-silico study |
Q91950846 | Gut microbial dysbiosis in individuals with Sjögren's syndrome |
Q50010788 | Gut microbiota and probiotics: novel immune system modulators in myasthenia gravis? |
Q64910156 | Host-Microbiome Synergistic Control on Sphingolipid Metabolism by Mechanotransduction in Model Arthritis. |
Q91890834 | Host-microbiota interactions in rheumatoid arthritis |
Q47266690 | Hybrid-denovo: A de novo OTU-picking pipeline integrating single-end and paired-end 16S sequence tags |
Q92876537 | Identification of a Shared Microbiomic and Metabolomic Profile in Systemic Autoimmune Diseases |
Q50067815 | Immunomodulatory interplay of the microbiome and therapy of rheumatic diseases. |
Q92739712 | Impact of commonly used drugs on the composition and metabolic function of the gut microbiota |
Q90291102 | Impact of the gut microbiota on immune checkpoint inhibitor-associated toxicities |
Q64106869 | Impacts of Duck-Origin Parvovirus Infection on Cherry Valley Ducklings From the Perspective of Gut Microbiota |
Q47547409 | Infectious Agents and Inflammation: The Role of Microbiota in Autoimmune Arthritis |
Q58781227 | Integrated Serum and Fecal Metabolomics Study of Collagen-Induced Arthritis Rats and the Therapeutic Effects of the Zushima Tablet |
Q95320368 | Interaction between microbiota and immunity in health and disease |
Q41692834 | Intestinal Dysbiosis and Rheumatoid Arthritis: A Link between Gut Microbiota and the Pathogenesis of Rheumatoid Arthritis. |
Q98735567 | Intestinal Dysbiosis and Tryptophan Metabolism in Autoimmunity |
Q38757039 | Intestinal dysbiosis and probiotic applications in autoimmune diseases. |
Q40200049 | Intestinal microbiota in individualized therapies |
Q46260350 | Low dietary fiber intake increases Collinsella abundance in the gut microbiota of overweight and obese pregnant women. |
Q37632332 | Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability |
Q46248509 | Microbiome at the Frontier of Personalized Medicine |
Q53581455 | Microbiome in 2016: T follicular helper cells and the gut microbiome in arthritis. |
Q48291240 | Microbiome, Immunomodulation, and the Neuronal System |
Q26739010 | Microbiota and chronic inflammatory arthritis: an interwoven link |
Q33754038 | Microbiota in T-cell homeostasis and inflammatory diseases |
Q39203697 | Microbiota, Immune Subversion, and Chronic Inflammation |
Q89427856 | Microbiota-Dependent Involvement of Th17 Cells in Murine Models of Inflammatory Arthritis |
Q89622588 | Molecular Characterization of Circulating Microbiome Signatures in Rheumatoid Arthritis |
Q91802495 | Mucosa-Environment Interactions in the Pathogenesis of Rheumatoid Arthritis |
Q59798416 | Multi-omic analysis of signalling factors in inflammatory comorbidities |
Q58703927 | Natural Products for the Treatment of Autoimmune Arthritis: Their Mechanisms of Action, Targeted Delivery, and Interplay with the Host Microbiome |
Q90267503 | Nutrition Interventions in Rheumatoid Arthritis: The Potential Use of Plant-Based Diets. A Review |
Q50333123 | Oral microbiota in autoimmune polyendocrine syndrome type 1. |
Q55711827 | Predictive Modeling of Microbiome Data Using a Phylogeny-Regularized Generalized Linear Mixed Model. |
Q57812807 | Probiotics in Autoimmune and Inflammatory Disorders |
Q61796314 | Recent Advances on Microbiota Involvement in the Pathogenesis of Autoimmunity |
Q89621226 | Relationships Between Vitamin D, Gut Microbiome, and Systemic Autoimmunity |
Q87726283 | Rheumatoid arthritis |
Q57165511 | Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction |
Q55025616 | Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. |
Q49741604 | Role of human microbiome and selected bacterial infections in the pathogenesis of rheumatoid arthritis. |
Q91709946 | Supplementation of diet with non-digestible oligosaccharides alters the intestinal microbiota, but not arthritis development, in IL-1 receptor antagonist deficient mice |
Q90680930 | Supply of Methionine During Late-Pregnancy Alters Fecal Microbiota and Metabolome in Neonatal Dairy Calves Without Changes in Daily Feed Intake |
Q94671452 | Synovial tissue transcriptomes of long-standing rheumatoid arthritis are dominated by activated macrophages that reflect microbial stimulation |
Q91755050 | T follicular helper cells and T follicular regulatory cells in rheumatic diseases |
Q48047320 | The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis |
Q58805868 | The Anti-Inflammatory Mediator, Vasoactive Intestinal Peptide, Modulates the Differentiation and Function of Th Subsets in Rheumatoid Arthritis |
Q60959001 | The Dietary Intervention of Transgenic Low-Gliadin Wheat Bread in Patients with Non-Celiac Gluten Sensitivity (NCGS) Showed No Differences with Gluten Free Diet (GFD) but Provides Better Gut Microbiota Profile |
Q64056578 | The Effects of Unfermented and Fermented Cow and Sheep Milk on the Gut Microbiota |
Q99238089 | The Gut Microbiome in Psychosis From Mice to Men: A Systematic Review of Preclinical and Clinical Studies |
Q26741414 | The Gut Microbiota in Immune-Mediated Inflammatory Diseases |
Q41525657 | The Gut Mucosal Firewall and Functional Medicine |
Q38819986 | The Microbiome: a Revolution in Treatment for Rheumatic Diseases? |
Q90345025 | The Role of Gut Microbiota and Environmental Factors in Type 1 Diabetes Pathogenesis |
Q45804014 | The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid Arthritis. |
Q55231467 | The canine gut microbiome is associated with higher risk of gastric dilatation-volvulus and high risk genetic variants of the immune system. |
Q33754027 | The interplay between host immune cells and gut microbiota in chronic inflammatory diseases |
Q89152959 | The microbiome in autoimmune diseases |
Q36105384 | The microbiome in rheumatic diseases : Driving force or confusing factor? |
Q64073396 | The parasitic worm product ES-62 normalises the gut microbiota bone marrow axis in inflammatory arthritis |
Q50072788 | The role of gut microbiota in the pathogenesis of rheumatic diseases. |
Q92736091 | The role of microbiome in rheumatoid arthritis treatment |
Q64247319 | The significance of microbiome in personalized medicine |
Q53609903 | Treatment-Seeking Behaviors of Persons With Rheumatoid Arthritis. |
Q89251200 | Update on the Gastrointestinal Microbiome in Systemic Sclerosis |
Q92723052 | VOLARE: visual analysis of disease-associated microbiome-immune system interplay |
Q49738250 | Vaccination Against Lawsonia intracellularis Decreases Shedding of Salmonella enterica serovar Typhimurium in Co-Infected Pigs and Alters the Gut Microbiome. |
Search more.